SHANGHAI RIGHTONGENE BIOTECHNOLOGY CO., LTD.

Autres langues Shanghai Rightongene Biotechnology Co., Ltd.

Actions

688217

CNE100005212

Equipement, fournitures et distribution médicale

Cours en clôture Shanghai S.E. 30/09/2026			Varia. 5j.	Varia. 1 janv.
25,65 ^CNY	-0,12%		-.--%	-2,66%

27/08	Shanghai Rightongene Biotechnology Co., Ltd. publie ses résultats pour le premier semestre clos le 30 juin 2026	CI
27/04	Shanghai Rightongene Biotechnology Co., Ltd. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

27/08	Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026
27/04	Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
27/02	Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
16/10/25	Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
08/09/25	Shanghai Rightongene Biotechnology's boards elects chairman
28/08/25	Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
24/04/25	Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
27/02/25	Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
25/02/25	Shanghai Rightongene Biotechnology Receives 1.8 Million Yuan in Government Subsidies
20/02/25	Tranche Update on Shanghai Rightongene Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 29, 2024.
18/02/25	Shanghai Rightongene Biotechnology Co., Ltd.'s Equity Buyback announced on February 29, 2024, has closed with 669,621 shares, representing 1.2% for CNY 17.02 million.
03/01/25	Tranche Update on Shanghai Rightongene Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 29, 2024.
29/10/24	Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
29/10/24	Rightongene Biotechnology's Chairman, Vice General Managers Arrested for Fraud Suspicion; Shares Down 4%
10/10/24	Tranche Update on Shanghai Rightongene Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 29, 2024.
29/08/24	Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
24/07/24	China stocks slide to five-month low; Hong Kong drops
24/07/24	China stocks flat; Hong Kong drops on EV stock losses
02/07/24	Tranche Update on Shanghai Rightongene Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 29, 2024.
26/04/24	Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
29/02/24	Shanghai Rightongene Biotechnology Co., Ltd. commences an Equity Buyback Plan for CNY 20 million worth of its shares, under the authorization approved on February 28, 2024.
23/02/24	Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
26/10/23	Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
28/08/23	Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
27/04/23	Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023